Fibrinogen concentrate used for congenital afibrinogenaemia and dysfibrinogenaemia
Irish Blood Transfusion Service
Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used in acquired hypofibrinogenemia conditions such as massive haemorrhage, acquired coagulopathy, liver disease with bleeding and in obstetric haemorrhage. The product should be licensed for these clinical indications and approved by the HPRA. Fibrinogen, in presence of thrombin, activates FVIII and calcium, which is necessary to convert fibrinogen into stable three-dimensional fibrin coagula. The IBTS is responsible for the distribution of fibrinogen to users nationwide. IBTS must therefore have a sufficient stock and a stable supply of fibrinogen concentrates to meet patient needs.
DeadlineThe time limit for receipt of tenders was 2023-07-28. The procurement was published on 2023-06-13.
Who? What?- • Medicinal products for the blood, blood-forming organs and the cardiovascular system › Medicinal products for the cardiovascular system
- • Medicinal products for the blood, blood-forming organs and the cardiovascular system › Medicinal products for the blood and blood-forming organs
| Date | Document |
|---|---|
| 2023-06-13 | Contract notice |
Object
Scope of the procurement
Title: Medicinal products for the blood, blood-forming organs and the cardiovascular system
Short description:
“Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used...”
Notice metadata
Original language: English 🗣️
Document type: Contract notice
Nature of contract: Supplies
Regulation: European Union
Common procurement vocabulary (CPV)
Code: Medicinal products for the blood, blood-forming organs and the cardiovascular system 📦
Additional CPV: Medicinal products for the blood and blood-forming organs 📦
Place of performance
NUTS region: Éire/Ireland 🏙️
Procedure
Procedure type: Open procedure
Type of bid: Submission for all lots
Award criteria
The most economic tender
Contracting authority
Identity
Country: Ireland 🇮🇪
Awarding authority type: Body governed by public law
Awarding authority name: Irish Blood Transfusion Service
Postal address: National Blood Centre , James’s Street
Postal code: D08 NH5R
Postal town: Dublin
Contact
Internet address: https://www.etenders.gov.ie 🌏
E-mail: brian.boland@ibts.ie 📧
URL for documents: https://www.etenders.gov.ie 🌏
URL for participation: https://www.etenders.gov.ie 🌏
Reference
Dates
Date dispatched: 2023-06-13 📅
Submission deadline: 2023-07-28 📅
Publication date: 2023-06-16 📅
Identifiers
Notice number: 2023/S 115-355453
OJ-S issue: 115
Object
Scope of the procurement
Duration: 36 months
Description of renewals:
“As per RFT”
Procedure
Legal basis: 32014L0024
Time of receipt of tenders: 12:00
Languages in which tenders or requests to participate may be submitted: English 🗣️
Tender validity period: 3 months
Tender opening date: 2023-07-28 📅
Tender opening time: 12:30
Contracting authority
Contact
Contact point: Brian Boland
Address of the buyer profile: https://www.etenders.gov.ie 🌏
Documents URL: https://www.etenders.gov.ie 🌏
Reference
Additional information
Estimated timing for further notices:
“As per RFT”
Complementary information
Review body
Name: Irish Blood Transfusion Services
Postal address: National Blood Centre , James’s Street
Postal town: Dublin
Postal code: D08 NH5R
Country: Ireland 🇮🇪
E-mail: brian.boland@ibts.ie 📧
Source: OJS 2023/S 115-355453 (2023-06-13)
- Medical equipments, pharmaceuticals and personal care products (8 new procurements)